In the last 2 decades, the cost of healthcare has risen, but the expectations of self-management for people with diabetes has stayed the same, which has made it more challenging to live with the disease, said Kellie Rodriguez, RN, MSN, MBA, CDE, director, Global Diabetes Program, Parkland Health & Hospital System.
In the last 2 decades, the cost of healthcare has risen, but the expectations of self-management for people with diabetes has stayed the same, which has made it more challenging to live with the disease, said Kellie Rodriguez, RN, MSN, MBA, CDE, director, Global Diabetes Program, Parkland Health & Hospital System.
Have the challenges of having diabetes changed for patients since you started your career?
I think so. I’ve been working in diabetes and diabetes education for about 22 years. I’m originally from Australia and the last 14 years here in the US. I think it definitely has changed. I think for patients, certainly from both the personal perspective as well as the perspective from the healthcare system.
So, on the personal perspective, the cost of healthcare is rising, the cost of living is rising, but the expectations of people living with diabetes are not changing. The expectations are there in terms of all the elements they need to do for successful self-care and management. All the lifestyle aspects which become more costly—healthy eating, exercise, all of those sorts of resources that are necessary, the monitoring supplies that are required for effective self-management, the medications, which we see a lot of in the news in relation to the cost of medications and having those available, and certainly now we’ve got so many more pharmacotherapies available, which is wonderful, but there’s sometimes a cost to that, as well.
So, I think there’s a lot of personal reasons why this becomes challenging. And certainly, as we’re seeing younger people developing diabetes, their living with diabetes longer, which is a good thing, but in the sense of cost, the cost of the disease is also a prolonged piece as well.
I think it’s also more challenging from the health system perspective. Healthcare is challenging, I think the changes in healthcare are difficult for people working in healthcare, nevermind for people not working in healthcare and having to navigate the system. With the increasing prevalence of diabetes, access to care, the complexities of care, and the way that we’re needing to change the way that we deliver care, requires very informed consumers of care in terms of people with diabetes. So, I think it is a more challenging environment, and it’s something that we really need to be mindful of because it’s really a disease of self-management.
Managed Care Cast Presents: BTK Inhibitors in Treatment-Naive Patients With CLL and MCL
December 26th 2024A trio of experts discuss the treatment of chronic lymphocytic leukemia (CLL) and mantle cell lymphoma (MCL) with Bruton tyrosine kinase (BTK) inhibitors, including cost considerations.
Listen
HS Treatment Goals: Better Quality of Life, Not Just Control
January 3rd 2025For part 3 of our discussion with Chris Sayed, MD, we tackle several important topics in the hidradenitis suppurative (HS) and inflammatory disease space: patient quality of life, medication and treatment goals, and the possibility of a cure.
Read More
Dr Yehuda Handelsman: DCRM Guidelines Are Shaping Integrated, Global CRM Care
January 3rd 2025In part 2 of our interview, Yehuda Handelsman, MD, discusses how cardiorenalmetabolic (CRM) disease management is advancing with the 2022 Diabetes, Cardiorenal, and Metabolic (DCRM) multispecialty practice recommendations and the updated DCRM 2.0 guidelines.
Read More
Stripped of Fucose, Powerful Monoclonal Antibody Shows Promising Results in MDS Dosing Study
January 2nd 2025Nicole Grieselhuber, MD, PhD, of The Ohio State University, discusses results from Part D of a dosing study involving patients with previously untreated higher-risk myelodysplastic syndrome (MDS) who were treated with a combination of SEA-CD70 and azacitidine.
Read More